Onderneming Reata Pharmaceuticals, Inc.
Aandelen
RETA
US75615P1030
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 322
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 01-09-22 |
Director of Finance/CFO | 60 | 26-09-23 | |
John Hunter
IRC | Investor Relations Contact | - | - |
Mike Visnick
PRN | Corporate Officer/Principal | - | 01-01-07 |
Robin Kral
PRN | Corporate Officer/Principal | - | 01-01-04 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 01-09-22 |
Director/Board Member | - | 26-09-23 | |
Michael Dambach
BRD | Director/Board Member | - | 26-09-23 |
Robin Kramer
BRD | Director/Board Member | - | 26-09-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 3 | 4 515 246 | 0 | 0 | 75,54 % |
Aandeel B | 1 | 33 331 586 | 28 588 243 ( 85,77 %) | 0 |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |